Patents by Inventor Charles E. Rogler

Charles E. Rogler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8729046
    Abstract: Methods are provided for treating fibrosis of a tissue, including fibrosis of the liver, using combinations of antagomirs and/or locked nucleic acids. Compositions therefor are also provided.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: May 20, 2014
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Leslie E. Rogler, Charles E. Rogler
  • Publication number: 20080293581
    Abstract: Provided are microarrays comprising spots comprising mixtures of cDNA molecules, the cDNA mixture being complementary and substantially quantitatively proportional to a mixture of mRNA molecules present in a cell or group of cells. Also provided are methods for determining expression of a gene in a cell or group of cells using the invention microarrays. Additionally provided are methods of determining the difference in expression of a first gene between a first cell or group of cells and a second cell or group of cells, using the invention microarrays. Also provided are microarrays comprising short RNAs, and methods of using these microarrays for detecting and quantifying microarrays in cells.
    Type: Application
    Filed: May 23, 2005
    Publication date: November 27, 2008
    Inventors: Charles E. Rogler, Tatyana Tchaikovskaya, Christopher Plescia
  • Patent number: 6864402
    Abstract: A method is provided for repopulating degenerated of immunetolerant mice which lack mature B and T lymphocytes with xenogenic mammalian hepatocytes, particularly primate hepatocytes to generate chimeric mice. In addition, a method of generating a human hepatitis virus-infected chimeric mouse is provided. A preferred xenogenic primate hepatocyte is derived from human, chimpanzee or baboon. These chimeric mice are useful in the investigation of host and viral mechanisms determining hepadnaviral persistence and hepatocarcinogenesis. Methods for monitoring the development of hepatitis and hepatocellular carcinoma as well as methods for testing and screening anti-viral and anti-cancer compounds with this model system are also provided.
    Type: Grant
    Filed: June 24, 1999
    Date of Patent: March 8, 2005
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Charles E. Rogler, Joerg Petersen
  • Publication number: 20040158885
    Abstract: A method is provided for repopulating degenerated of immunetolerant mice which lack mature B and T lymphocytes with xenogenic mammalian hepatocytes, particularly primate hepatocytes to generate chimeric mice. In addition, a method of generating a human hepatitis virus-infected chimeric mouse is provided. A preferred xenogenic primate hepatocyte is derived from human, chimpanzee or baboon. These chimeric mice are useful in the investigation of host and viral mechanisms determining hepadnaviral persistence and hepatocarcinogenesis. Methods for monitoring the development of hepatitis and hepatocellular carcinoma as well as methods for testing and screening anti-viral and anti-cancer compounds with this model system are also provided.
    Type: Application
    Filed: March 19, 2004
    Publication date: August 12, 2004
    Applicant: Albert Einstein College of Medicine of Yeshiva University, a division of Yeshiva University
    Inventors: Charles E. Rogler, Joerg Petersen